Share
Other content recommended for you
- Cognitive neuroenhancement: false assumptions in the ethical debate
- True and false concerns about neuroenhancement: a response to ‘Neuroenhancers, addiction and research ethics’, by D M Shaw
- Sugar addiction: is it real? A narrative review
- Neuroenhancing public health
- Neuropsychiatry of the basal ganglia
- Extrastriatal dopaminergic changes in Parkinson’s disease patients with impulse control disorders
- Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology
- The use of methylphenidate among students: the future of enhancement?
- Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
- Tobacco industry litigation position on addiction: continued dependence on past views